🔗 Share this article

The prestigious award in medical science has been granted for revolutionary discoveries that illuminate how the immune system targets dangerous pathogens while protecting the body's own cells.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—share this accolade.

Their work identified unique "security guards" within the defense system that eliminate rogue immune cells capable of harming the body.

These findings are now enabling innovative treatments for autoimmune diseases and malignancies.

These laureates will share a monetary award worth 11 million Swedish kronor.

Crucial Findings

"Their work has been essential for understanding how the body's defenses operates and the reason we don't all develop serious self-attack conditions," stated the head of the Nobel Committee.

The team's studies explain a core question: In what way does the immune system defend us from countless invaders while keeping our healthy cells unharmed?

The immune system uses immune cells that scan for indicators of infection, including pathogens and germs it has never encountered.

Such cells employ sensors—called recognition units—that are produced by chance in a vast number of variations.

This provides the immune system the ability to combat a broad range of threats, but the unpredictability of the process inevitably creates immune cells that may target the body.

Security Guards of the Immune System

Researchers previously knew that some of these harmful defense cells were eliminated in the immune organ—the site where white blood cells mature.

This year's award recognizes the discovery of regulatory T-cells—described as the body's "security guards"—which patrol the body to neutralize any immune cells that assault the healthy cells.

It is known that this process fails in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.

The prize committee stated, "The discoveries have laid the foundation for a new field of research and accelerated the creation of new treatments, for instance for tumors and immune disorders."

In malignancies, regulatory T-cells block the system from fighting the tumor, so studies are aimed at lowering their numbers.

In self-attack disorders, trials are exploring increasing T-reg cells so the body is no longer being harmed. A comparable approach could also be effective in minimizing the chances of transplanted organ failure.

Innovative Experiments

Prof Shimon Sakaguchi, of Osaka University, performed tests on mice that had their immune gland removed, leading to self-attack conditions.

He demonstrated that introducing defense cells from other animals could stop the illness—suggesting there was a system for blocking defenders from attacking the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an inherited autoimmune disease in mice and people that led to the identification of a genetic factor critical for the way T-regs operate.

"Their groundbreaking research has revealed how the body's defenses is controlled by T-reg cells, stopping it from mistakenly attacking the healthy cells," commented a leading physiology expert.

"This research is a striking example of how fundamental biological study can have far-reaching consequences for public health."